Publication | Open Access
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
429
Citations
21
References
2020
Year
Our results suggest that methylprednisolone pulse could be an efficient therapeutic agent for hospitalised severe COVID-19 patients at the pulmonary phase.
| Year | Citations | |
|---|---|---|
Page 1
Page 1